Furthermore, the application of ADAM17 as a clinical parameter for the detection of ovarian cancer must be qualified by the fact that other diseases, such as Alzheimer’s disease, rheumatoid arthritis, and ANCA-associated vasculitis, can also lead to elevated ADAM17 levels. This evidence concerns the gene ADAM17 and Alzheimer disease.